CUTISS AG
8952 Schlieren, Grabenstrasse 11
+41 44 244 36 60
info@cutiss.swiss
After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.
CUTISS AG
Grabenstrasse 11
8952 Schlieren
1 Ergebnisse für "biotherapeutics" unter CUTISS AG
Über uns – CUTISS
... leitende Positionen bei Modex Therapeutics, DFB Pharmaceuticals, Healthpoint Biotherapeutics, Smith ... Biotherapeutics, Smith & Nephew (Schweiz und USA) und dem Skin Research Institute in Singapur besetzt. Kathi hat ...
